Pulike Biological Engineering, Inc. (SHA:603566)

China flag China · Delayed Price · Currency is CNY
14.21
+0.30 (2.16%)
Jul 14, 2025, 2:45 PM CST
14.14%
Market Cap 4.76B
Revenue (ttm) 1.09B
Net Income (ttm) 118.41M
Shares Out 341.92M
EPS (ttm) 0.35
PE Ratio 40.07
Forward PE 27.10
Dividend 0.40 (2.88%)
Ex-Dividend Date Jun 11, 2025
Volume 6,547,700
Average Volume 4,385,590
Open 14.17
Previous Close 13.91
Day's Range 13.99 - 14.36
52-Week Range 10.80 - 15.53
Beta 0.34
RSI 58.38
Earnings Date Aug 29, 2025

About SHA:603566

Pulike Biological Engineering, Inc. engages in the research and development, production, and marketing of veterinary biological products and drugs. It offers vaccines, antibodies, and medicines for swine and poultry, as well as disinfectants. The company was founded in 1995 and is headquartered in Luoyang, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1995
Employees 1,551
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603566
Full Company Profile

Financial Performance

In 2024, SHA:603566's revenue was 1.04 billion, a decrease of -16.77% compared to the previous year's 1.25 billion. Earnings were 92.81 million, a decrease of -46.82%.

Financial Statements

News

There is no news available yet.